Repair what is lost: Neuroprotection through neural stem cells in progressive MS

Cell Rep Med. 2023 Mar 21;4(3):100985. doi: 10.1016/j.xcrm.2023.100985.

Abstract

Genchi et al.1 report the first phase 1 trial of neural stem cell transplantation in multiple sclerosis showing a reduction in gray matter atrophy. Results give hope for a new era of induced neuroprotection, especially in progressive multiple sclerosis.

MeSH terms

  • Gray Matter
  • Humans
  • Multiple Sclerosis* / therapy
  • Multiple Sclerosis, Chronic Progressive* / therapy
  • Neural Stem Cells*
  • Neuroprotection